Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
The University of Texas MD Anderson Cancer Center · Memorial Sloan Kettering Cancer Center · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
637
total citations
- FWCI
- 22.00
- Percentile
- 100%
- References
- 65
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Ipilimumab
- Medicine
- Immunotherapy
- Food and drug administration
- Prostate cancer
- Clinical trial
- Cancer
- Melanoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.